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Background: The search for Chlamydia trachomatis or its com-
ponents at the site of the primary infection or in the joint is
the optimal approach to conﬁrm chlamydial aetiology of Reac-
tive Arthritis (ReA). The most speciﬁc diagnosis of C. trachomatis
induced-ReA ismadebydetection of thepathogen in the joint itself.
Undifferentiated Spondyloarthropathy (uSpA) patients generally
have asymptomatic ReA. Also, themajority of infections are asymp-
tomatic in both males and females, hence, diagnosis during these
phase is a challenging task. 1 - 15% patients with genital infection
subsequently develop acute arthritis which later becomes chronic.
No diagnostic modalities are available till date for such cases. We
aim to detect C. trachomatis using various diagnostic methods in
Synovial Fluid (SF) and urine and correlate these ﬁndings with age,
sex, duration/ development of disease.
Methods & Materials: With the permission of hospital ethics
committee, studywas conducted in 115 arthritic patients, viz.:ReA/
uSpA (n- 45) / Rheumatoid Arthritis (n- 35)/ Osteoarthritis (n- 35).
SF/ urine samples were investigated for C. trachomatis infection
by various molecular/ non-molecular methods of diagnosis, viz:
nucleic acid ampliﬁcation test, anti-C. trachomatis IgA antibodies
and direct ﬂuorescence assay. Data was clinically correlated and
statistically analyzed.
Results: 91% (10/11) PCR-positive ReA/ uSpA patients for C.
trachomatis in SF and 77% (10/13) anti-C. trachomatis IgA-positive
patients had chronic infection (diseaseduration >06months)while
83.3% (5/6) patients positive for C. trachomatis by DFA in urine had
an acute infection (disease duration < 06 months). Further, DFA
in urine followed by PCR in SF was able to detect C. trachomatis
infection in 83.3% (5/6), 63.6 (7/11), respectively in 18-30 years age
group. 91% male ReA/ uSpA patients had C. trachomatis infection.
69.2% (9/13) ReA/uSpA symptomatic patients had anti-C. trachoma-
tis IgA antibodies in SF.
Conclusion: This study demonstrated that PCR and anti-C.
trachomatis IgA in SF might be useful techniques to differenti-
ate between acute and chronic chlamydial infection, respectively;
while male patients in the younger age group are more prone to
develop C. trachomatis-induced ReA.
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The evaluation and risk assessment of sexually
transmitted disease in Korean adolescents at
risk
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Background: There have been little researches of sexually
transmitted infection (STI) for adolescent at risk in Korea and these
studies were just for prevalence limited to Chlamydia trichomonas
and Neisseria gonorrheae. We explored prevalences and risk fac-
tors of 10 pathogens of STI at risk adolescent. Through conducting
treatment model, we aim to develop a substantial management
plan.
Methods & Materials: Total of 237 subjects in one youth pro-
tection center and ﬁve probation ofﬁces were examined in Korea.
First-voided urine specimens were collected for analysis of C. tra-
chomatis, N. gonorrhoeae, Trichomonas vaginalis, Mycoplasma.
hominis, Mycoplasma genitalium, Ureaplasma. urealyticum, Ure-
aplasmaparvumbynucleic acid ampliﬁcation tests usingmultiplex
real-time PCR and VDRL titer, HSV-1 & 2 IgG and HIV Ag/Ab were
tested by serum. Through anonymous, self-administered, struc-
tured questionnaire, basic characteristics and risk factors were
collected. We conducted treatment model for adolescents who
were infected with STI and agreed to treatment.
Results: The prevalence of C. trachomatis (13.9%) was the high-
est followed by N. gonorrhoeae (1.7%), T. vaginalis (0.8%), syphilis
(0.8%), HSV (0.4%) and HIV (0%). The prevalence of U. urealyticum
(24.7) was the highest in other infectious diseases followed by U.
parvum (24.1%), M. hominis (17.3%), M. genitalium (4.2%). There
were no signiﬁcant association in family structure, economic sta-
tus and psychologic factors with STI. Only past STI history was
signiﬁcant difference according to infection (OR = 7.039, 95% CI =
2.051-24.157, P <0.001). Total of 88 (66.2%) adolescents treated in
our treatment model and 89.6% were satisﬁed with discovery of
STI, connection to treatment and explanation of medical team.
Conclusion: Prevalence of STI at risk adolescents is similar level
as adults in Korea and institutionalization of screening and treat-
ment for adolescents is needed. Screening system should include at
least chlamydia and gonorrhea and one stop system from screening
to treatment will be effective.
http://dx.doi.org/10.1016/j.ijid.2016.02.465
